Attached files
file | filename |
---|---|
8-K - FORM 8-K - MEDTRONIC INC | c63508e8vk.htm |
EX-1.1 - EX-1.1 - MEDTRONIC INC | c63508exv1w1.htm |
EX-4.1 - EX-4.1 - MEDTRONIC INC | c63508exv4w1.htm |
Exhibit 99.1
NEWS RELEASE
Contacts: | ||
Brian Henry | ||
Public Relations | ||
763-505-2796 | ||
Jeff Warren | ||
Investor Relations | ||
763-505-2696 |
MEDTRONIC ANNOUNCES PUBLIC OFFERING OF SENIOR NOTES
MINNEAPOLIS March 10, 2011 Medtronic, Inc. (NYSE:MDT) today announced a registered offering
of $500 million of its 2.625% Senior Notes due 2016 and $500 million of its 4.125% Senior Notes due
2021 (collectively, the Notes). Medtronic intends to use the net proceeds for working capital and
general corporate purposes, which may include repayment of its indebtedness.
The Notes will be senior, unsecured obligations of Medtronic and will rank equally with all of
Medtronics existing and future senior, unsecured debt and senior to all of Medtronics
subordinated debt.
This press release is not an offer to sell or the solicitation of an offer to buy nor shall there
be any sale of such Notes in any jurisdiction in which such offer, solicitation or sale would be
unlawful prior to registration or qualification under the securities laws of such jurisdiction. The
offering of these securities is being made only by means of a base prospectus (as supplemented and
amended from time to time), which is part of a registration statement that Medtronic filed with the
U.S. Securities and Exchange
Commission utilizing a shelf registration process (collectively, the Prospectus). Copies of the
Prospectus may be obtained from Medtronic Inc. at 710 Medtronic Pkwy NE LC-480, Minneapolis, MN
55432, Attn: Investor Relations Department, (763) 505-2692.
About Medtronic
Medtronic, Inc., headquartered in Minneapolis, is the worlds leading medical technology company,
alleviating pain, restoring health and extending life for people with chronic disease.
This press release contains forward-looking statements regarding our intended use of proceeds
and anticipated use of our shelf registration statement, which are subject to risks and
uncertainties, such as our ability to market and sell the Notes, our continued eligibility to use
the shelf registration statement, general economic conditions and other risks and uncertainties
described in Medtronics filings with the Securities and Exchange Commission. Actual results may
differ materially from anticipated results. Medtronic does not undertake to update its
forward-looking statements.
-end-